A downtrend has been apparent in Globus Medical (GMED) lately. While the stock has lost 8.8% over the past week, it could ...

Globus Medical’s modeled fair value has been adjusted from US$106.40 to about US$109.54, a small move that still matters if you are tracking the stock closely. That change comes as Street research ...

If you are wondering whether Globus Medical's current share price reflects its true worth, you are not alone; many investors are asking the same question. The stock last closed at US$87.81, with a 7 ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter ...

Across the recent three months, 8 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...

Detailed price information for Globus Medical Inc (GMED-N) from The Globe and Mail including charting and trades.

Invesco Ltd‘s “Small Cap Value Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here. The Invesco Small Cap Value Fund reported strong results for Q4 2025, ...

Across the recent three months, 11 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent ...

The latest price target for Globus Medical (NYSE:GMED) was reported by JMP Securities on May 27, 2025. The analyst firm set a price target for $0.00 expecting GMED to fall to within 12 months (a ...

CEO Dan Scavilla noted that Q1 revenue was $598 million, with a slight decline of 0.8% year-over-year on a constant currency basis. Issues impacting sales included temporary supply chain disruptions, ...

Robotic-assisted surgery is moving from a nice-to-have differentiator to a core capability in modern operating rooms—especially in spine and orthopedic ...

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced a new leadership structure to enhance organizational alignment and ...